Immunotherapy is the 2016 Clinical Cancer Advance of the Year and a promising new strategy for treating cancer. But how far have we come? The American Society of Clinical Oncology (ASCO) justified this year’s choice of Clinical Cancer Advance, immunotherapy, by the fact that no recent advance has been more transformative, particularly over this past … Continue reading A paradigm-shift in cancer?
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed